Tag: Uppsala University
Oncolytic Virus Clinical Trial for Neuroendocrine Tumor Patients Begins at Uppsala University, Sweden
It is with great excitement that we share the announcement of the start of the AdVince clinical trial for neuroendocrine cancer patients at Uppsala University in Sweden – the oncolytic virus is on its way to the first patient in the trial!!
New Jersey Carcinoid Cancer NETwork Conference in November, Registration through October 16
Three of the country’s leading carcinoid and neuroendocrine cancer specialists will be featured speakers for the New Jersey Carcinoid Cancer NETwork Conference. to be held on Saturday, November 2, 2013 at the Crowne Plaza in Edison, New Jersey. Carcinoid/NETs: …READ MORE
A Possible Cure for Neuroendocrine Cancer: Exciting Update!
Back in September 2012 we shared the following: “For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor. At Uppsala University in Sweden researchers are ready to start a …READ MORE
Unique Lung Carcinoid Conference to Feature European and American Physicians
When Dr. Dan Granberg, a leading carcinoid and neuroendocrine cancer specialist at Uppsala University in Sweden, joins Dr. Eric H. Liu, Director of the Neuroendocrine Tumor Center at Vanderbilt University Medical Center in Nashville, Tennessee, …READ MORE
10 Highlights of the Year 2012 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2012, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community. Here are 10 of the year’s important stories:
1) NET Cancer Day, November …READ MORE
Archived Neuroendocrine Tumor Webinar by Dr. Eric Liu Now Available
Dr. Eric H. Liu, Director of the Neuroendocrine Center and Director of Surgical Services at Vanderbilt University Medical Center in Tennessee, presented a live webinar on August 22, 2012 entitled Imaging of Neuroendocrine Tumors and Obstacles to Diagnosis.…READ MORE
A Possible Cure for Neuroendocrine Cancer — It Can Be Named for You or a Loved One
For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor. At Uppsala University in Sweden researchers are ready to start a clinical trial for up to 20 NET (neuroendocrine tumor)…READ MORE